MSAFP levels and oesophageal atresia

This study was undertaken to evaluate the relationship between maternal serum alpha-fetoprotein (MSAFP) levels and oesophageal atresia (OA). OA occurred in 16 fetuses of mothers who had an MSAFP test in the study interval. The multiple of the median (MOM) value for MSAFP averaged 1·54 ± 0·65 (range 0·5–2·9 MOM), which was significantly higher than the value seen in controls. The median MOM was 1·35. Using a cut-off of 2·5 MOM, the sensitivity of MSAFP for detecting OA was 19 per cent. Although OA should be considered in the differential diagnosis of an elevated MSAFP level, MSAFP cannot be considered an appropriate screening test for OA given the low sensitivity.     

Dystrophin protein and rflp analyis for fetal diagnosis and carrier confirmation of duchenne muscular dystrophy

A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated.     

聚氧硫酸根合高铁处理选煤废水实验研究

讨论了聚氧硫酸根合高铁处理煤泥水的作用机理及使用的影响因素，有助于选择厂实现洗煤水闭路循环，以提高选煤厂的经济效益和社会效益。     

仪器法测定工业废水中COD的方法探讨

使用XH 90 0 1型COD快速测定仪测定COD的实验方法 ,通过t检验、F检验判明了仪器法无显著性差异。与国家标准一重铬酸钾法相比 ,仪器法简便快速 ,适合样品量少、均匀、COD值大于 60mg/L的测定     

改性沸石对焦化废水中COD的去除研究

本文研究了沸石经NaCl、NaOH、HDTMA(溴化十六烷基三甲胺)改性后对焦化废水中的COD的去除效果.比较得出HDTMA改性沸石对COD的去除能力较好,而且废水的色度明显减小.接着进一步研究了该废水处理过程中的影响因素,包括吸附时间、烘干温度、改性剂HDTMA的浓度、pH值等.结果表明,HDTMA改性沸石处理焦化废水可使其COD的浓度降低至150mg/L以下,这到污水综合排放二级标准.     

火电厂烟气脱硫工艺国产化初探

火电厂排放的SO2形成酸雨已严重危害人类生存环境。国家把解决烟气脱硫问题纳入大政方针之中，强制要求火电厂必须安装烟气脱硫装置。文章介绍了几种目前国际上较为成熟的脱硫工艺，并对各种工艺进行了比较，分析了国内烟气脱硫市场，并就脱硫技术国产化问题提出若干看法。     

催化CODcr快速测法的精密度与准确度实验

化学需氧量标准分析方法测定时间长、操作繁琐。本实验采用CTL—BX3C型便携式COD快速测定仪能在20分钟获得COD数据，同时耗能低、省时省力、减少污染。催化CODcr快速法的精密度与准确度均能达到要求。     

活性污泥数学模型中进水易降解有机物的测定

ASM系列模型 (ASMs)自推出以来在欧美得到广泛应用。要想利用ASMs对特定污水处理过程进行准确的模拟 ,首先必须得到该过程污水的水质特性参数。介绍了连续式OUR计量法、序批式OUR计量法和絮凝过滤物理化学法等 3种测定ASMs中进水易降解有机物的方法 ,通过分析比较指出了各自的优缺点及适用情况。     

Service transformation—managing a shift from business travel to virtual meetings

It has been shown that the potential for environmental, and financial improvements through the increased substitution of in-person meetings by virtual communication is considerable. However, it has also been shown that this potential is not automatically realized by investing in the technology that can enable virtual meetings. This paper describes two case studies that explored the factors that influenced communication and meeting behavior. A number of drivers and barriers for virtual meetings are identified, and, in addition, measures are proposed to improve the utilization of virtual tools for business communication.     

可持续发展与战略环境评价

可持续发展的实施需要具体的手段和方法。在对可持续发展和战略环境评价（SEA）的概念、内涵和特征进行概略分析的基础上,通过分析两者之间的内在联系,着重考察以SEA实施可持续发展的理论依据和方法。结果表明：SEA能为实施可持续发展提供整体性方法,全面考虑战略替代方案,系统分析累积环境影响,建立环境监控计划及运用适应性环境管理方法,扩展决策过程中的公众参与。认为SEA是实施可持续发展的一种重要工具。为了贯彻实施我国的可持续发展战略,应在我国进一步开展SEA的理论和实践研究。